Cancer Diagnostics Market: New biomarkers could lead to urine test for preeclampsia
Cancer Diagnostics Market was pegged at $168.60 billion in 2020, and is estimated to reach $280.59 billion by 2028, growing at a CAGR of 6.9% from 2020 to 2028.
PORTLAND, OREGON, UNITED STATES, February 8, 2022 /EINPresswire.com/ -- According to the report by Allied Market Research, titled, "Cancer Biomarkers Market1 by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, and Cytogenetics Based Tests), Biomolecule (Genetic Biomarkers, Protein Biomarkers, and Glyco-biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, and Others), and Application (Diagnostics, Drug Discovery and Development, Prognostics,Risk Assessment, and Others): Global Opportunity Analysis and Industry Forecast, 2020โ2027". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.
Increase in incidences and prevalence of various cancer types, initiatives by government and other organizations to spread awareness about cancer, and surge in number of diagnostics laboratories in developed countries drive the growth of the global cancer diagnostics market. However, risk of high radiation exposure by the use of CT scanners and high cost associated with diagnostics imaging systems hinder the market growth. On the contrary, development of diagnostic approaches for various cancer mutations is expected to create lucrative opportunities for the market players in the future.
Request The Free Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/11701
The global Cancer Diagnostics Market was pegged at $168.60 billion in 2020, and is estimated to reach $280.59 billion by 2028, growing at a CAGR of 6.9% from 2020 to 2028.
Comprehensive competitive analysis and profiles of major market players, such as
The global cancer diagnostics market includes an in-depth analysis of the prime market players such as Becton, Dickinson and Company, Abbott Laboratories, Roche Holdings AG (F. Hoffmann-La Roche Ltd.), Bio-Rad Laboratories, Inc., Hologic, Inc., Danaher Corporation (GE Healthcare), Qiagen N.V., Koninklijke Philips N.V. (Philips Healthcare), Thermo Fisher Scientific., and Siemens Healthcare GmbH.
Key Benefits For Stakeholders:
By profiling technologies,the omic technologies segment accounted for the highest market share of 54% in 2019,and is anticipated to grow at the fastest rate during the forecast period.
By region, North America was the major shareholder and accounted for the highest share of 36% in 2019.
Based on cancer type, thebreast cancersegment is expected to grow at a CAGR of 16.7% during the forecast period.
On the basis of biomolecules, the genetic biomarkers segment dominated the market in 2019 and is anticipated to maintain its dominance during the forecast period.
๐๐ฒ๐ ๐ฑ๐ฒ๐๐ฎ๐ถ๐น๐ฒ๐ฑ ๐๐ข๐ฉ๐๐-๐ญ๐ต ๐ถ๐บ๐ฝ๐ฎ๐ฐ๐ ๐ฎ๐ป๐ฎ๐น๐๐๐ถ๐@ ๐ฅ๐ฒ๐พ๐๐ฒ๐๐ ๐๐ผ๐ฟ ๐๐๐๐๐ผ๐บ๐ถ๐๐ฎ๐๐ถ๐ผ๐ป: https://www.alliedmarketresearch.com/request-for-customization/1443
Table of Content:
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING
3.4. PORTERโS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunitiesโฆ
๐๐ป๐๐ฒ๐ฟ๐ฒ๐๐๐ฒ๐ฑ ๐ถ๐ป ๐ฃ๐ฟ๐ผ๐ฐ๐๐ฟ๐ถ๐ป๐ด ๐๐ต๐ถ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐? ๐ฉ๐ถ๐๐ถ๐ ๐๐ฒ๐ฟ๐ฒ: https://www.alliedmarketresearch.com/cancer-biomarkers-market
FREQUENTLY ASKED QUESTIONS?
Q1. What is the total market value of cancer biomarkers market report ?
Q2. What is the market value of cancer biomarkers market in 2020?
Q3. Which is base year calculated in the cancer biomarkers market report?
Q4. Which are the top companies hold the market share in cancer biomarkers market?
Q5. Which is the most influencing segment growing in the cancer biomarkers market report?
Q6. What are the key trends in the cancer biomarkers market report?
Q7. What are the market values / growth % of emerging countries?
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
โWe have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.โ
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Gastrointestinal Stents Market2 - Global Opportunity Analysis and Industry Forecast, 2020โ2028
Gastrointestinal Therapeutics Market3 - Global Opportunity Analysis and Industry Forecast, 2019-2028
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
1 https://www.alliedmarketresearch.com/cancer-biomarkers-market
2 https://www.alliedmarketresearch.com/gastrointestinal-stents-market
3 https://www.alliedmarketresearch.com/gastrointestinal-therapeutics-market